A recent study published in the Journal of Infectious Diseases estimates that the economic burden of long COVID in the U.S. will exceed $8 billion between 2025 and 2027, according to fortune.com. This projection highlights the ongoing financial impact of long COVID, despite reduced media coverage compared to earlier in the pandemic.
The research team, composed of public health and infectious disease experts, developed a computational simulation model to assess outcomes for individuals after COVID-19 infection. The model accounted for the risk of developing various long COVID symptoms, associated healthcare costs, and lost work productivity. Their findings indicate that a single case of long COVID could cost between $9,906 and $11,646 annually, with productivity losses representing over 90% of these costs.
This study underscores the substantial and continuing economic toll of long COVID on the U.S. economy. With more than 44 million Americans having reported long COVID symptoms at some point, the financial strain from healthcare expenses and reduced workforce productivity remains significant. The findings provide a quantitative basis for policymakers and healthcare providers to consider the long-term consequences of COVID-19 beyond immediate infection rates.
Looking ahead, the study’s projections through 2027 suggest that addressing long COVID will require sustained attention and resources. Continued research and public health strategies may focus on mitigating productivity losses and managing healthcare costs associated with long COVID symptoms. Monitoring these economic impacts will be crucial for informing future health policy decisions.